Table of Content

Open Access iconOpen Access

RESIDENT’S CORNER

Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male

Shahab Hillyer , Frederick A. Gulmi

Department of Urology, Brookdale University Hospital and Medical Center, Brooklyn, New York, USA
Address correspondence to Dr. Shahab Hillyer, Department of Urology, Brookdale University Hospital, 1 Brookdale Plaza, Brooklyn, New York 11212 USA

Canadian Journal of Urology 2009, 16(5), 4866-4869.

Abstract

Objective: Transitional cell carcinoma of the bladder is commonly treated with intravesical BCG. We report a cutaneous complication of BCG after therapy in 66-year-old male 4 years after initiating treatment.
Materials and methods: A case review including pathological slides, laboratory data, and radiographic findings.
Results: Biopsy findings showed an ill defined granulomatous process with chronic inflammation and necrosis.
Conclusion: The patient was managed on antituberculous therapy for a period of 6 months with resolution of symptoms.

Keywords

BCG therapy, superfi cial bladder cancer, penile lesion

Cite This Article

APA Style
Hillyer, S., Gulmi, F.A. (2009). Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male. Canadian Journal of Urology, 16(5), 4866–4869.
Vancouver Style
Hillyer S, Gulmi FA. Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male. Can J Urology. 2009;16(5):4866–4869.
IEEE Style
S. Hillyer and F.A. Gulmi, “Cutaneous BCG of the penis after intravesical therapy for bladder cancer: a case report in a 66-year-old male,” Can. J. Urology, vol. 16, no. 5, pp. 4866–4869, 2009.



Copyright © 2009 The Canadian Journal of Urology.
  • 165

    View

  • 155

    Download

  • 0

    Like

Share Link